Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Acta Tropica
|
June 27, 2003
The epidemiology and consequences of maternal malaria: a review of immunological basis
Brown J Okoko, G Enwere, M O C Ota
Annals of Tropical Paediatrics
|
January 30, 1999
Bacteraemia in cerebral malaria
G Enwere, M B Van Hensbroek, R Adegbola, et al.
The New England Journal of Medicine
|
July 11, 1996
A trial of artemether or quinine in children with cerebral malaria
M B van Hensbroek, E Onyiorah, S Jaffar, et al.
The Journal of Infectious Diseases
|
November 1, 1996
The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria
M B van Hensbroek, A Palmer, E Onyiorah, et al.
Vaccine
|
June 3, 2008
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia
M Saaka, B J Okoko, R C Kohberger, et al.
Lancet (London, England)
|
March 30, 2005
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
F T Cutts, S M A Zaman, G Enwere, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Acta Tropica
|
June 27, 2003
The epidemiology and consequences of maternal malaria: a review of immunological basis
Brown J Okoko, G Enwere, M O C Ota
Annals of Tropical Paediatrics
|
January 30, 1999
Bacteraemia in cerebral malaria
G Enwere, M B Van Hensbroek, R Adegbola, et al.
The New England Journal of Medicine
|
July 11, 1996
A trial of artemether or quinine in children with cerebral malaria
M B van Hensbroek, E Onyiorah, S Jaffar, et al.
The Journal of Infectious Diseases
|
November 1, 1996
The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria
M B van Hensbroek, A Palmer, E Onyiorah, et al.
Vaccine
|
June 3, 2008
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia
M Saaka, B J Okoko, R C Kohberger, et al.
Lancet (London, England)
|
March 30, 2005
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
F T Cutts, S M A Zaman, G Enwere, et al.
Page
of 1